Seventh Sense Biosystems

Primary contact

Seventh Sense Biosystems is a privately held medical technology company focused on developing innovative blood collection devices used in research and clinical testing. It has developed TAP (Touch-Activated Phlebotomy), a proprietary push-button blood collection device and platform that can be used to draw capillary blood in a one-step process without requiring venous access. TAP also simplifies and standardizes blood collection, and may help minimize variables that can impact sample and test quality.
Primary contact

Funding 💰

Total $54.5M
Select investors Flagship Pioneering, Polaris Partners, LabCorp, Novartis, next47, Third Rock Ventures, Bill & Melinda Gates Foundation
Last update: May 14, 2018